{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T19:49:49Z","timestamp":1782762589112,"version":"3.54.5"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,29]]},"DOI":"10.7759\/cureus.111753","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T19:34:42Z","timestamp":1782761682000},"source":"Crossref","is-referenced-by-count":0,"title":["Management of Inflammatory Myofibroblastic Tumor of Urinary Bladder With Partial Cystectomy: A Case Report"],"prefix":"10.7759","author":[{"given":"Kieran T","family":"Raj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Stratton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4132\/jptm.2017.01.12","article-title":"Clinicopathological study of 18 cases of inflammatory myofibroblastic tumors with reference to ALK-1 expression: 5-year experience in a tertiary care center","volume":"51","author":"Telugu RB","year":"2017","unstructured":"Telugu RB, Prabhu AJ, Kalappurayil NB, Mathai J, Gnanamuthu BR, Manipadam MT. Clinicopathological study of 18 cases of inflammatory myofibroblastic tumors with reference to ALK-1 expression: 5-year experience in a tertiary care center. J Pathol Transl Med. 2017, 51:255-63. 10.4132\/jptm.2017.01.12","journal-title":"J Pathol Transl Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.34132","article-title":"Inflammatory myofibroblastic tumor: a multi-institutional study from the Pediatric Surgical Oncology Research Collaborative","volume":"151","author":"Rich BS","year":"2022","unstructured":"Rich BS, Fishbein J, Lautz T, et al.. Inflammatory myofibroblastic tumor: a multi-institutional study from the Pediatric Surgical Oncology Research Collaborative. Int J Cancer. 2022, 151:1059-67. 10.1002\/ijc.34132","journal-title":"Int J Cancer"},{"key":"ref3","unstructured":"National Cancer Institute. (2019). Accessed. April 11, 2025: https:\/\/www.cancer.gov\/pediatric-adult-rare-tumor\/rare-tumors\/rare-soft-tissue-tumors\/inflammatory-myofibroblastic-tumor."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/iju.iju_50_24","article-title":"Inflammatory myofibroblastic tumor of the urinary bladder: a systematic review of the literature and report of a case","volume":"40","author":"Hage L","year":"2024","unstructured":"Hage L, O'Donnell MA, Abou Chakra M, Kime A, Sibony M, Peyromaure M, Duquesne I. Inflammatory myofibroblastic tumor of the urinary bladder: a systematic review of the literature and report of a case. Indian J Urol. 2024, 40:88-95. 10.4103\/iju.iju_50_24","journal-title":"Indian J Urol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000213393.57322.c7","article-title":"Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases","volume":"31","author":"Coffin CM","year":"2007","unstructured":"Coffin CM, Hornick JL, Fletcher CD. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol. 2007, 31:509-20. 10.1097\/01.pas.0000213393.57322.c7","journal-title":"Am J Surg Pathol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2014.05.039","article-title":"Inflammatory myofibroblastic tumors of the urinary bladder: a systematic review","volume":"84","author":"Teoh JY","year":"2014","unstructured":"Teoh JY, Chan NH, Cheung HY, Hou SS, Ng CF. Inflammatory myofibroblastic tumors of the urinary bladder: a systematic review. Urology. 2014, 84:503-8. 10.1016\/j.urology.2014.05.039","journal-title":"Urology"},{"key":"ref7","article-title":"Urinary and Male Genital Tumours, 5th ed","author":"WHO Classification of Tumours Editorial Board","year":"2022","unstructured":"WHO Classification of Tumours Editorial Board. Urinary and Male Genital Tumours, 5th ed. IARC Press, Lyon, France; 2022."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2023.2636","article-title":"Inflammatory myofibroblastic tumor of the bladder: computed tomographic features","volume":"18","author":"Liang P","year":"2023","unstructured":"Liang P, Zhu BB, Ren XC, Gao JB. Inflammatory myofibroblastic tumor of the bladder: computed tomographic features. Mol Clin Oncol. 2023, 18:40. 10.3892\/mco.2023.2636","journal-title":"Mol Clin Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1007056","article-title":"Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor","volume":"363","author":"Butrynski JE","year":"2010","unstructured":"Butrynski JE, D'Adamo DR, Hornick JL, et al.. Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. N Engl J Med. 2010, 363:1727-33. 10.1056\/NEJMoa1007056","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2021.07.016","article-title":"Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE","volume":"156","author":"Sch\u00f6ffski P","year":"2021","unstructured":"Sch\u00f6ffski P, Kubickova M, Wozniak A, et al.. Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE. Eur J Cancer. 2021, 156:12-23. 10.1016\/j.ejca.2021.07.016","journal-title":"Eur J Cancer"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-023-01144-6","article-title":"Update of diagnosis and targeted therapy for ALK(+) inflammation myofibroblastic tumor","volume":"24","author":"Wang QA","year":"2023","unstructured":"Wang QA, Chen HW, Wu RC, Wu CE. Update of diagnosis and targeted therapy for ALK(+) inflammation myofibroblastic tumor. Curr Treat Options Oncol. 2023, 24:1683-702. 10.1007\/s11864-023-01144-6","journal-title":"Curr Treat Options Oncol"},{"key":"ref12","unstructured":"FDA approves crizotinib for inflammatory myofibroblastic tumors. (2022). Accessed. April 10, 2025: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-crizotinib-alk-positive-inflammatory-myof...."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2024.108388","article-title":"Treatment and outcomes in pediatric inflammatory myofibroblastic tumors - a systematic review of published studies","volume":"50","author":"Raitio A","year":"2024","unstructured":"Raitio A, Losty PD. Treatment and outcomes in pediatric inflammatory myofibroblastic tumors - a systematic review of published studies. Eur J Surg Oncol. 2024, 50:108388. 10.1016\/j.ejso.2024.108388","journal-title":"Eur J Surg Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3182a0218f","article-title":"GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors","volume":"38","author":"Miettinen M","year":"2014","unstructured":"Miettinen M, McCue PA, Sarlomo-Rikala M, et al.. GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors. Am J Surg Pathol. 2014, 38:13-22. 10.1097\/PAS.0b013e3182a0218f","journal-title":"Am J Surg Pathol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.831952","article-title":"Inflammatory myofibroblastic tumor of the urinary bladder: an 11-year retrospective study from a single center","volume":"9","author":"Chen C","year":"2022","unstructured":"Chen C, Huang M, He H, et al.. Inflammatory myofibroblastic tumor of the urinary bladder: an 11-year retrospective study from a single center. Front Med (Lausanne). 2022, 9:831952. 10.3389\/fmed.2022.831952","journal-title":"Front Med (Lausanne)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/bju.15638","article-title":"Clinicopathological analysis and outcomes of inflammatory myofibroblastic tumours of the urinary bladder","volume":"130","author":"Hensley PJ","year":"2022","unstructured":"Hensley PJ, Bree KK, Guo CC, Lobo N, Campbell MT, Pettaway CA, Kamat AM. Clinicopathological analysis and outcomes of inflammatory myofibroblastic tumours of the urinary bladder. BJU Int. 2022, 130:604-10. 10.1111\/bju.15638","journal-title":"BJU Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59040791","article-title":"Inflammatory myofibroblastic tumour of the urinary bladder in a middle-aged man-a case report of an unusual localization of a rare tumour","volume":"59","author":"Prijovic N","year":"2023","unstructured":"Prijovic N, Santric V, Babic U, et al.. Inflammatory myofibroblastic tumour of the urinary bladder in a middle-aged man-a case report of an unusual localization of a rare tumour. Medicina (Kaunas). 2023, 59:10.3390\/medicina59040791","journal-title":"Medicina (Kaunas)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.826705","article-title":"Case report: early distant metastatic inflammatory myofibroblastic tumor harboring EML4-ALK fusion gene: study of two typical cases and review of literature","volume":"9","author":"Han Q","year":"2022","unstructured":"Han Q, He X, Cui L, Qiu Y, Li Y, Chen H, Zhang H. Case report: early distant metastatic inflammatory myofibroblastic tumor harboring EML4-ALK fusion gene: study of two typical cases and review of literature. Front Med (Lausanne). 2022, 9:826705. 10.3389\/fmed.2022.826705","journal-title":"Front Med (Lausanne)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27012","article-title":"Inflammatory myofibroblastic tumors: a retrospective analysis of the Cooperative Weichteilsarkom Studiengruppe","volume":"65","author":"Kube S","year":"2018","unstructured":"Kube S, Vokuhl C, Dantonello T, et al.. Inflammatory myofibroblastic tumors: a retrospective analysis of the Cooperative Weichteilsarkom Studiengruppe. Pediatr Blood Cancer. 2018, 65:e27012. 10.1002\/pbc.27012","journal-title":"Pediatr Blood Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/418945-management-of-inflammatory-myofibroblastic-tumor-of-urinary-bladder-with-partial-cystectomy-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T19:34:47Z","timestamp":1782761687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/418945-management-of-inflammatory-myofibroblastic-tumor-of-urinary-bladder-with-partial-cystectomy-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.111753","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,29]]}}}